The demand for weight-loss medication in India is escalating rapidly, as competition between Eli Lilly and Novo Nordisk intensifies, according to data from Pharmarack. Lilly's product, Mounjaro, saw a ...

Lilly's obesity drug Mounjaro's sales rise 60% in India amid rising demand The US drugmaker sold ₹12.6 crore ($1.5 million) worth of the injections last month, according to market analysis firm ...